Skip to main content
Top
Published in: Systematic Reviews 1/2013

Open Access 01-12-2013 | Research

Economic analyses of breast cancer control in low- and middle-income countries: a systematic review

Authors: Sten G Zelle, Rob M Baltussen

Published in: Systematic Reviews | Issue 1/2013

Login to get access

Abstract

Background

To support the development of global strategies against breast cancer, this study reviews available economic evidence on breast cancer control in low- and middle-income countries (LMICs).

Methods

A systematic article search was conducted through electronic scientific databases, and studies were included only if they concerned breast cancer, used original data, and originated from LMICs. Independent assessment of inclusion criteria yielded 24 studies that evaluated different kinds of screening, diagnostic, and therapeutic interventions in various age and risk groups. Studies were synthesized and appraised through the use of a checklist, designed for evaluating economic analyses.

Results

The majority of these studies were of poor quality, particularly in examining costs. Studies demonstrated the economic attractiveness of breast cancer screening strategies, and of novel treatment and diagnostic interventions.

Conclusions

This review shows that the evidence base to guide strategies for breast cancer control in LMICs is limited and of poor quality. The limited evidence base suggests that screening strategies may be economically attractive in LMICs – yet there is very little evidence to provide specific recommendations on screening by mammography versus clinical breast examination, the frequency of screening, or the target population. These results demonstrate the need for more economic analyses that are of better quality, cover a comprehensive set of interventions and result in clear policy recommendations.
Appendix
Available only for authorised users
Literature
1.
go back to reference Abegunde DO, Mathers CD, Adam T, Ortegon M, Strong K: The burden and costs of chronic diseases in low-income and middle-income countries. Lancet. 2007, 370: 1929-1938. 10.1016/S0140-6736(07)61696-1.CrossRefPubMed Abegunde DO, Mathers CD, Adam T, Ortegon M, Strong K: The burden and costs of chronic diseases in low-income and middle-income countries. Lancet. 2007, 370: 1929-1938. 10.1016/S0140-6736(07)61696-1.CrossRefPubMed
2.
go back to reference Beaglehole R, Bonita R, Horton R, Adams C, Alleyne G, Asaria P, Baugh V, Bekedam H, Billo N, Casswell S, Cecchini M, Colagiuri R, Colagiuri S, Collins T, Ebrahim S, Engelgau M, Galea G, Gaziano T, Geneau R, Haines A, Hospedales J, Jha P, Keeling A, Leeder S, Lincoln P, McKee M, Mackay J, Magnusson R, Moodie R, Mwatsama M, Lancet NCDAG, Alliance NCD: Priority actions for the non-communicable disease crisis. Lancet. 2011, 377: 1438-1447. 10.1016/S0140-6736(11)60393-0.CrossRefPubMed Beaglehole R, Bonita R, Horton R, Adams C, Alleyne G, Asaria P, Baugh V, Bekedam H, Billo N, Casswell S, Cecchini M, Colagiuri R, Colagiuri S, Collins T, Ebrahim S, Engelgau M, Galea G, Gaziano T, Geneau R, Haines A, Hospedales J, Jha P, Keeling A, Leeder S, Lincoln P, McKee M, Mackay J, Magnusson R, Moodie R, Mwatsama M, Lancet NCDAG, Alliance NCD: Priority actions for the non-communicable disease crisis. Lancet. 2011, 377: 1438-1447. 10.1016/S0140-6736(11)60393-0.CrossRefPubMed
3.
go back to reference Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN. Int J Cancer. 2008, 127: 2893-2917.CrossRef Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN. Int J Cancer. 2008, 127: 2893-2917.CrossRef
4.
go back to reference The good news about cancer in developing countries. Lancet. 2011, 378: 1605-10.1016/S0140-6736(11)61681-4. The good news about cancer in developing countries. Lancet. 2011, 378: 1605-10.1016/S0140-6736(11)61681-4.
5.
go back to reference Jemal A, Thun MJ, Ries LA, Howe HL, Weir HK, Center MM, Ward E, Wu XC, Eheman C, Anderson R, Ajani UA, Kohler B, Edwards BK: Annual report to the nation on the status of cancer, 1975–2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst. 2008, 100: 1672-1694. 10.1093/jnci/djn389.CrossRefPubMedPubMedCentral Jemal A, Thun MJ, Ries LA, Howe HL, Weir HK, Center MM, Ward E, Wu XC, Eheman C, Anderson R, Ajani UA, Kohler B, Edwards BK: Annual report to the nation on the status of cancer, 1975–2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst. 2008, 100: 1672-1694. 10.1093/jnci/djn389.CrossRefPubMedPubMedCentral
6.
go back to reference Levi F, Lucchini F, Negri E, La Vecchia C: Continuing declines in cancer mortality in the European Union. Ann Oncol. 2007, 18: 593-595.CrossRefPubMed Levi F, Lucchini F, Negri E, La Vecchia C: Continuing declines in cancer mortality in the European Union. Ann Oncol. 2007, 18: 593-595.CrossRefPubMed
7.
go back to reference Duffy SW, Tabar L, Olsen AH, Vitak B, Allgood PC, Chen TH, Yen AM, Smith RA: Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England. J Med Screen. 2010, 17: 25-30. 10.1258/jms.2009.009094.CrossRefPubMedPubMedCentral Duffy SW, Tabar L, Olsen AH, Vitak B, Allgood PC, Chen TH, Yen AM, Smith RA: Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England. J Med Screen. 2010, 17: 25-30. 10.1258/jms.2009.009094.CrossRefPubMedPubMedCentral
8.
go back to reference Gotzsche PC, Hartling OJ, Nielsen M, Brodersen J, Jorgensen KJ: Breast screening: the facts – or maybe not. BMJ. 2009, 338: b86-10.1136/bmj.b86.CrossRefPubMed Gotzsche PC, Hartling OJ, Nielsen M, Brodersen J, Jorgensen KJ: Breast screening: the facts – or maybe not. BMJ. 2009, 338: b86-10.1136/bmj.b86.CrossRefPubMed
9.
go back to reference Kopans DB, Smith RA, Duffy SW: Mammographic screening and ‘overdiagnosis’. Radiology. 2011, 260: 616-620. 10.1148/radiol.11110716.CrossRefPubMed Kopans DB, Smith RA, Duffy SW: Mammographic screening and ‘overdiagnosis’. Radiology. 2011, 260: 616-620. 10.1148/radiol.11110716.CrossRefPubMed
10.
go back to reference Boyle P, Levin B: World Cancer Report 2008. 2008, Lyon: International Agency for Research on Cancer (IARC) Boyle P, Levin B: World Cancer Report 2008. 2008, Lyon: International Agency for Research on Cancer (IARC)
11.
go back to reference Coleman MP, Forman D, Bryant H, Butler J, Rachet B, Maringe C, Nur U, Tracey E, Coory M, Hatcher J, McGahan CE, Turner D, Marrett L, Gjerstorff ML, Johannesen TB, Adolfsson J, Lambe M, Lawrence G, Meechan D, Morris EJ, Middleton R, Steward J, Richards MA: Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet. 2011, 377: 127-138. 10.1016/S0140-6736(10)62231-3.CrossRefPubMedPubMedCentral Coleman MP, Forman D, Bryant H, Butler J, Rachet B, Maringe C, Nur U, Tracey E, Coory M, Hatcher J, McGahan CE, Turner D, Marrett L, Gjerstorff ML, Johannesen TB, Adolfsson J, Lambe M, Lawrence G, Meechan D, Morris EJ, Middleton R, Steward J, Richards MA: Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet. 2011, 377: 127-138. 10.1016/S0140-6736(10)62231-3.CrossRefPubMedPubMedCentral
12.
go back to reference Vainio H, Bianchini F: IARC Handbook of Cancer Prevention. Breast Cancer Screening. 2002, Lyon: IARC Press, 7 Vainio H, Bianchini F: IARC Handbook of Cancer Prevention. Breast Cancer Screening. 2002, Lyon: IARC Press, 7
13.
go back to reference De Koning HJ: Breast cancer screening; cost-effective in practice?. Eur J Radiol. 2000, 33: 32-37. 10.1016/S0720-048X(99)00105-9.CrossRefPubMed De Koning HJ: Breast cancer screening; cost-effective in practice?. Eur J Radiol. 2000, 33: 32-37. 10.1016/S0720-048X(99)00105-9.CrossRefPubMed
14.
go back to reference Eddy DM: Screening for breast cancer. Ann Intern Med. 1989, 111: 389-399. 10.7326/0003-4819-111-5-389.CrossRefPubMed Eddy DM: Screening for breast cancer. Ann Intern Med. 1989, 111: 389-399. 10.7326/0003-4819-111-5-389.CrossRefPubMed
15.
go back to reference Lindfors KK, Rosenquist CJ: The cost-effectiveness of mammographic screening strategies. JAMA. 1995, 274: 881-884. 10.1001/jama.1995.03530110043033.CrossRefPubMed Lindfors KK, Rosenquist CJ: The cost-effectiveness of mammographic screening strategies. JAMA. 1995, 274: 881-884. 10.1001/jama.1995.03530110043033.CrossRefPubMed
16.
go back to reference Stout NK, Rosenberg MA, Trentham-Dietz A, Smith MA, Robinson SM, Fryback DG: Retrospective cost-effectiveness analysis of screening mammography. J Natl Cancer Inst. 2006, 98: 774-782. 10.1093/jnci/djj210.CrossRefPubMed Stout NK, Rosenberg MA, Trentham-Dietz A, Smith MA, Robinson SM, Fryback DG: Retrospective cost-effectiveness analysis of screening mammography. J Natl Cancer Inst. 2006, 98: 774-782. 10.1093/jnci/djj210.CrossRefPubMed
17.
go back to reference Anderson BO, Cazap E, El Saghir NS, Yip CH, Khaled HM, Otero IV, Adebamowo CA, Badwe RA, Harford JB: Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010. Lancet Oncol. 2011, 12: 387-398. 10.1016/S1470-2045(11)70031-6.CrossRefPubMed Anderson BO, Cazap E, El Saghir NS, Yip CH, Khaled HM, Otero IV, Adebamowo CA, Badwe RA, Harford JB: Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010. Lancet Oncol. 2011, 12: 387-398. 10.1016/S1470-2045(11)70031-6.CrossRefPubMed
18.
go back to reference Corbex M, Burton R, Sancho-Garnier H: Breast cancer early detection methods for low and middle income countries, a review of the evidence. Breast (Edinburgh, Scotland). 2012, 21: 428-434. 10.1016/j.breast.2012.01.002.CrossRef Corbex M, Burton R, Sancho-Garnier H: Breast cancer early detection methods for low and middle income countries, a review of the evidence. Breast (Edinburgh, Scotland). 2012, 21: 428-434. 10.1016/j.breast.2012.01.002.CrossRef
19.
go back to reference Ginsburg OM, Love RR: Breast cancer: a neglected disease for the majority of affected women worldwide. Breast J. 2011, 17: 289-295. 10.1111/j.1524-4741.2011.01067.x.CrossRefPubMedPubMedCentral Ginsburg OM, Love RR: Breast cancer: a neglected disease for the majority of affected women worldwide. Breast J. 2011, 17: 289-295. 10.1111/j.1524-4741.2011.01067.x.CrossRefPubMedPubMedCentral
20.
go back to reference Harford JB, Otero IV, Anderson BO, Cazap E, Gradishar WJ, Gralow JR, Kane GM, Niens LM, Porter PL, Reeler AV, Rieger PT, Shockney LD, Shulman LN, Soldak T, Thomas DB, Thompson B, Winchester DP, Zelle SG, Badwe RA: Problem solving for breast health care delivery in low and middle resource countries (LMCs): consensus statement from the Breast Health Global Initiative. Breast (Edinburgh, Scotland). 2011, 20 (Suppl 2): S20-S29.CrossRef Harford JB, Otero IV, Anderson BO, Cazap E, Gradishar WJ, Gralow JR, Kane GM, Niens LM, Porter PL, Reeler AV, Rieger PT, Shockney LD, Shulman LN, Soldak T, Thomas DB, Thompson B, Winchester DP, Zelle SG, Badwe RA: Problem solving for breast health care delivery in low and middle resource countries (LMCs): consensus statement from the Breast Health Global Initiative. Breast (Edinburgh, Scotland). 2011, 20 (Suppl 2): S20-S29.CrossRef
21.
go back to reference Autier P, Boniol M, La Vecchia C, Vatten L, Gavin A, Hery C, Heanue M: Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database. BMJ. 2010, 341: c3620-10.1136/bmj.c3620.CrossRefPubMedPubMedCentral Autier P, Boniol M, La Vecchia C, Vatten L, Gavin A, Hery C, Heanue M: Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database. BMJ. 2010, 341: c3620-10.1136/bmj.c3620.CrossRefPubMedPubMedCentral
23.
go back to reference Greene FL, Compton CC, Fritz AG: AJCC Cancer Staging Atlas. 2006, New York: SpringerCrossRef Greene FL, Compton CC, Fritz AG: AJCC Cancer Staging Atlas. 2006, New York: SpringerCrossRef
24.
go back to reference Drummond MF, Jefferson TO: Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. BMJ (Clin Res Ed). 1996, 313: 275-283. 10.1136/bmj.313.7052.275.CrossRef Drummond MF, Jefferson TO: Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. BMJ (Clin Res Ed). 1996, 313: 275-283. 10.1136/bmj.313.7052.275.CrossRef
25.
go back to reference Gerard K, Seymour J, Smoker I: A tool to improve quality of reporting published economic analyses. Int J Technol Assess Health Care. 2000, 16: 100-110. 10.1017/S0266462300016196.CrossRefPubMed Gerard K, Seymour J, Smoker I: A tool to improve quality of reporting published economic analyses. Int J Technol Assess Health Care. 2000, 16: 100-110. 10.1017/S0266462300016196.CrossRefPubMed
26.
go back to reference Denewer A, Hussein O, Farouk O, Elnahas W, Khater A, El-Saed A: Cost-effectiveness of clinical breast assessment-based screening in rural Egypt. World J Surg. 2010, 34: 2204-2210. 10.1007/s00268-010-0620-3.CrossRefPubMed Denewer A, Hussein O, Farouk O, Elnahas W, Khater A, El-Saed A: Cost-effectiveness of clinical breast assessment-based screening in rural Egypt. World J Surg. 2010, 34: 2204-2210. 10.1007/s00268-010-0620-3.CrossRefPubMed
27.
go back to reference Ginsberg GM, Lauer JA, Zelle S, Baeten S, Baltussen R: Cost effectiveness of strategies to combat breast, cervical, and colorectal cancer in sub-Saharan Africa and South East Asia: mathematical modelling study. BMJ. 2012, 344: e614-10.1136/bmj.e614.CrossRefPubMedPubMedCentral Ginsberg GM, Lauer JA, Zelle S, Baeten S, Baltussen R: Cost effectiveness of strategies to combat breast, cervical, and colorectal cancer in sub-Saharan Africa and South East Asia: mathematical modelling study. BMJ. 2012, 344: e614-10.1136/bmj.e614.CrossRefPubMedPubMedCentral
28.
go back to reference Groot MT, Baltussen R, Uyl-De Groot CA, Anderson BO, Hortobágyi GN: Costs and health effects of breast cancer interventions in epidemiologically different regions of Africa, North America, and Asia. Breast J. 2006, 12: S81-S90. 10.1111/j.1075-122X.2006.00206.x.CrossRefPubMed Groot MT, Baltussen R, Uyl-De Groot CA, Anderson BO, Hortobágyi GN: Costs and health effects of breast cancer interventions in epidemiologically different regions of Africa, North America, and Asia. Breast J. 2006, 12: S81-S90. 10.1111/j.1075-122X.2006.00206.x.CrossRefPubMed
29.
go back to reference Mousavi SM, Harirchi I, Ebrahimi M, Mohagheghi MA, Montazeri A, Jarrahi AM, Gouya MM, Miller AB: Screening for breast cancer in Iran: a challenge for health policy makers. Breast J. 2008, 14: 605-606. 10.1111/j.1524-4741.2008.00662.x.CrossRefPubMed Mousavi SM, Harirchi I, Ebrahimi M, Mohagheghi MA, Montazeri A, Jarrahi AM, Gouya MM, Miller AB: Screening for breast cancer in Iran: a challenge for health policy makers. Breast J. 2008, 14: 605-606. 10.1111/j.1524-4741.2008.00662.x.CrossRefPubMed
30.
go back to reference Okonkwo QL, Draisma G, der Kinderen A, Brown ML, de Koning HJ: Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India. J Natl Cancer Inst. 2008, 100: 1290-1300. 10.1093/jnci/djn292.CrossRefPubMed Okonkwo QL, Draisma G, der Kinderen A, Brown ML, de Koning HJ: Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India. J Natl Cancer Inst. 2008, 100: 1290-1300. 10.1093/jnci/djn292.CrossRefPubMed
31.
go back to reference Salomon JA, Carvalho N, Gutierrez-Delgado C, Orozco R, Mancuso A, Hogan DR, Lee D, Murakami Y, Sridharan L, Medina-Mora ME, Gonzalez-Pier E: Intervention strategies to reduce the burden of non-communicable diseases in Mexico: cost effectiveness analysis. Br Med J. 2012, 344: S20-S29. 10.1136/bmj.e20.CrossRef Salomon JA, Carvalho N, Gutierrez-Delgado C, Orozco R, Mancuso A, Hogan DR, Lee D, Murakami Y, Sridharan L, Medina-Mora ME, Gonzalez-Pier E: Intervention strategies to reduce the burden of non-communicable diseases in Mexico: cost effectiveness analysis. Br Med J. 2012, 344: S20-S29. 10.1136/bmj.e20.CrossRef
32.
go back to reference Sarvazyan A, Egorov V, Son JS, Kaufman CS: Cost-effective screening for breast cancer worldwide: current state and future directions. Breast Cancer. 2008, 1: 91-99.PubMedPubMedCentral Sarvazyan A, Egorov V, Son JS, Kaufman CS: Cost-effective screening for breast cancer worldwide: current state and future directions. Breast Cancer. 2008, 1: 91-99.PubMedPubMedCentral
33.
go back to reference Szynglarewicz B, Matkowski R: Low cost of cancer detection in the first year of mammographic screening in Poland. Breast (Edinburgh, Scotland). 2011, 20: 585-10.1016/j.breast.2011.08.135.CrossRef Szynglarewicz B, Matkowski R: Low cost of cancer detection in the first year of mammographic screening in Poland. Breast (Edinburgh, Scotland). 2011, 20: 585-10.1016/j.breast.2011.08.135.CrossRef
34.
go back to reference Yazihan N, Yilmaz HH: Breast cancer in Turkey: economic efficiency and cost effectiveness. 2006, 740: S20-S29. Yazihan N, Yilmaz HH: Breast cancer in Turkey: economic efficiency and cost effectiveness. 2006, 740: S20-S29.
35.
go back to reference Zelle SG, Nyarko KM, Bosu WK, Aikins M, Niens LM, Lauer JA, Sepulveda CR, Hontelez JA, Baltussen R: Costs, effects and cost-effectiveness of breast cancer control in Ghana. Trop Med Int Health. 2012, 17: 1031-1043. 10.1111/j.1365-3156.2012.03021.x.CrossRefPubMed Zelle SG, Nyarko KM, Bosu WK, Aikins M, Niens LM, Lauer JA, Sepulveda CR, Hontelez JA, Baltussen R: Costs, effects and cost-effectiveness of breast cancer control in Ghana. Trop Med Int Health. 2012, 17: 1031-1043. 10.1111/j.1365-3156.2012.03021.x.CrossRefPubMed
37.
go back to reference Boutayeb S, Boutayeb A, Ahbeddou N, Boutayeb W, Essaadi I, Tazi M, Errihani H: Estimation of the cost of treatment by chemotherapy for early breast cancer in Morocco. Cost Eff Resour Alloc. 2010, 8: 16-10.1186/1478-7547-8-16.CrossRefPubMedPubMedCentral Boutayeb S, Boutayeb A, Ahbeddou N, Boutayeb W, Essaadi I, Tazi M, Errihani H: Estimation of the cost of treatment by chemotherapy for early breast cancer in Morocco. Cost Eff Resour Alloc. 2010, 8: 16-10.1186/1478-7547-8-16.CrossRefPubMedPubMedCentral
38.
go back to reference Fonseca M, Araujo GT, Saad ED: Cost-effectiveness of anastrozole, in comparison with tamoxifen, in the adjuvant treatment of early breast cancer in Brazil. Rev Assoc Med Bras. 2009, 55: 410-415. 10.1590/S0104-42302009000400015.CrossRefPubMed Fonseca M, Araujo GT, Saad ED: Cost-effectiveness of anastrozole, in comparison with tamoxifen, in the adjuvant treatment of early breast cancer in Brazil. Rev Assoc Med Bras. 2009, 55: 410-415. 10.1590/S0104-42302009000400015.CrossRefPubMed
39.
go back to reference Liubao P, Xiaomin W, Chongqing T, Karnon J, Gannong C, Jianhe L, Wei C, Xia L, Junhua C: Cost-effectiveness analysis of adjuvant therapy for operable breast cancer from a Chinese perspective: doxorubicin plus cyclophosphamide versus docetaxel plus cyclophosphamide. PharmacoEconomics. 2009, 27: 873-886. 10.2165/11314750-000000000-00000.CrossRefPubMed Liubao P, Xiaomin W, Chongqing T, Karnon J, Gannong C, Jianhe L, Wei C, Xia L, Junhua C: Cost-effectiveness analysis of adjuvant therapy for operable breast cancer from a Chinese perspective: doxorubicin plus cyclophosphamide versus docetaxel plus cyclophosphamide. PharmacoEconomics. 2009, 27: 873-886. 10.2165/11314750-000000000-00000.CrossRefPubMed
40.
go back to reference Love RR, Duc NB, Allred DC, Binh NC, Dinh NV, Kha NN, Thuan TV, Mohsin SK, Roanh LD, Khang HX, Tran TL, Quy TT, Thuy NV, Thé PN, Cau TT, Tung ND, Huong DT, Quang LM, Hien NN, Thuong L, Shen TZ, Xin Y, Zhang Q, Havighurst TC, Yang YF, Hillner BE, DeMets DL: Oophorectomy and tamoxifen adjuvant therapy in premenopausal Vietnamese and Chinese women with operable breast cancer. J Clin Oncol. 2002, 20: 2559-2566. 10.1200/JCO.2002.08.169.CrossRefPubMed Love RR, Duc NB, Allred DC, Binh NC, Dinh NV, Kha NN, Thuan TV, Mohsin SK, Roanh LD, Khang HX, Tran TL, Quy TT, Thuy NV, Thé PN, Cau TT, Tung ND, Huong DT, Quang LM, Hien NN, Thuong L, Shen TZ, Xin Y, Zhang Q, Havighurst TC, Yang YF, Hillner BE, DeMets DL: Oophorectomy and tamoxifen adjuvant therapy in premenopausal Vietnamese and Chinese women with operable breast cancer. J Clin Oncol. 2002, 20: 2559-2566. 10.1200/JCO.2002.08.169.CrossRefPubMed
41.
go back to reference Munshi A: Resource-sparing and cost-effective strategies in current management of breast cancer. J Canc Res Ther. 2009, 5: 116-120. 10.4103/0973-1482.52797.CrossRef Munshi A: Resource-sparing and cost-effective strategies in current management of breast cancer. J Canc Res Ther. 2009, 5: 116-120. 10.4103/0973-1482.52797.CrossRef
42.
go back to reference Bai Y, Ye M, Cao H, Ma X, Xu Y, Wu B: Economic evaluation of radiotherapy for early breast cancer after breast-conserving surgery in a health resource-limited setting. Breast Cancer Res Tr. 2012, 136: 547-557. 10.1007/s10549-012-2268-1.CrossRef Bai Y, Ye M, Cao H, Ma X, Xu Y, Wu B: Economic evaluation of radiotherapy for early breast cancer after breast-conserving surgery in a health resource-limited setting. Breast Cancer Res Tr. 2012, 136: 547-557. 10.1007/s10549-012-2268-1.CrossRef
43.
go back to reference Arredondo A, Lockett LY, de Icaza E: Cost of diseases in Brazil: breast cancer, enteritis, cardiac valve disease and bronchopneumonia. Rev Saude Publica. 1995, 29: 349-354.CrossRefPubMed Arredondo A, Lockett LY, de Icaza E: Cost of diseases in Brazil: breast cancer, enteritis, cardiac valve disease and bronchopneumonia. Rev Saude Publica. 1995, 29: 349-354.CrossRefPubMed
44.
go back to reference Kobayashi T: International trends in the economics of breast examination. Ultrasound Med Biol. 1988, 14 (Suppl 1): 217-229.CrossRefPubMed Kobayashi T: International trends in the economics of breast examination. Ultrasound Med Biol. 1988, 14 (Suppl 1): 217-229.CrossRefPubMed
45.
go back to reference Thomas JO, Amanguno AU, Adeyi OA, Adesina AO: Fine needle aspiration (FNA) in the management of palpable masses in Ibadan: impact on the cost of care. Cytopathology. 1999, 10: 206-210. 10.1046/j.1365-2303.1999.00187.x.CrossRefPubMed Thomas JO, Amanguno AU, Adeyi OA, Adesina AO: Fine needle aspiration (FNA) in the management of palpable masses in Ibadan: impact on the cost of care. Cytopathology. 1999, 10: 206-210. 10.1046/j.1365-2303.1999.00187.x.CrossRefPubMed
46.
go back to reference Guggisberg K, Okorie C, Khalil M: Cytopathology including fine-needle aspiration in sub-Saharan Africa: a Cameroon experience. Arch Pathol Lab Med. 2011, 135: 200-206.PubMed Guggisberg K, Okorie C, Khalil M: Cytopathology including fine-needle aspiration in sub-Saharan Africa: a Cameroon experience. Arch Pathol Lab Med. 2011, 135: 200-206.PubMed
47.
go back to reference Nasrinossadat A, Ladan F, Fereshte E, Asieh O, Reza C, Akramossadat S, Golshan M: Marking non-palpable breast masses with injected methylene blue dye, an easy, safe and low cost method for developing countries and resource-limited areas. Asian Pac J Cancer P. 2011, 12: 1189-1192. Nasrinossadat A, Ladan F, Fereshte E, Asieh O, Reza C, Akramossadat S, Golshan M: Marking non-palpable breast masses with injected methylene blue dye, an easy, safe and low cost method for developing countries and resource-limited areas. Asian Pac J Cancer P. 2011, 12: 1189-1192.
48.
go back to reference Pakseresht S, Ingle GK, Garg S, Singh MM: Expenditure audit of women with breast cancer in a tertiary care hospital of Delhi. Indian J Cancer. 2011, 48: 428-437. 10.4103/0019-509X.92263.CrossRefPubMed Pakseresht S, Ingle GK, Garg S, Singh MM: Expenditure audit of women with breast cancer in a tertiary care hospital of Delhi. Indian J Cancer. 2011, 48: 428-437. 10.4103/0019-509X.92263.CrossRefPubMed
49.
go back to reference Bastani P, Kiadaliri AA: Cost–utility analysis of adjuvant therapies for breast cancer in Iran. Int J Technol Assess. 2012, 28: 110-114. 10.1017/S0266462312000049.CrossRef Bastani P, Kiadaliri AA: Cost–utility analysis of adjuvant therapies for breast cancer in Iran. Int J Technol Assess. 2012, 28: 110-114. 10.1017/S0266462312000049.CrossRef
50.
go back to reference Gluud LL: Bias in clinical intervention research. Am J Epidemiol. 2006, 163: 493-501. 10.1093/aje/kwj069.CrossRefPubMed Gluud LL: Bias in clinical intervention research. Am J Epidemiol. 2006, 163: 493-501. 10.1093/aje/kwj069.CrossRefPubMed
51.
go back to reference Gerkens S, Crott R, Cleemput I, Thissen JP, Closon MC, Horsmans Y, Beguin C: Comparison of three instruments assessing the quality of economic evaluations: a practical exercise on economic evaluations of the surgical treatment of obesity. Int J Technol Assess. 2008, 24: 318-325.CrossRef Gerkens S, Crott R, Cleemput I, Thissen JP, Closon MC, Horsmans Y, Beguin C: Comparison of three instruments assessing the quality of economic evaluations: a practical exercise on economic evaluations of the surgical treatment of obesity. Int J Technol Assess. 2008, 24: 318-325.CrossRef
52.
go back to reference Sculpher MJ, Pang FS, Manca A, Drummond MF, Golder S, Urdahl H, Davies LM, Eastwood A: Generalisability in economic evaluation studies in healthcare: a review and case studies. Health Technol Assess. 2004, 8: 1-192.CrossRef Sculpher MJ, Pang FS, Manca A, Drummond MF, Golder S, Urdahl H, Davies LM, Eastwood A: Generalisability in economic evaluation studies in healthcare: a review and case studies. Health Technol Assess. 2004, 8: 1-192.CrossRef
53.
go back to reference Sun X, Wang L, Li Y: Methodological issues in cost-effectiveness studies: a brief overview. J Evid Based Med. 2010, 3: 201-204. 10.1111/j.1756-5391.2010.01098.x.CrossRefPubMed Sun X, Wang L, Li Y: Methodological issues in cost-effectiveness studies: a brief overview. J Evid Based Med. 2010, 3: 201-204. 10.1111/j.1756-5391.2010.01098.x.CrossRefPubMed
54.
go back to reference Briggs AH, Claxton K, Sculpher MJ: Decision Modelling for Health Economic Evaluation. 2006, New York: Oxford University Press Briggs AH, Claxton K, Sculpher MJ: Decision Modelling for Health Economic Evaluation. 2006, New York: Oxford University Press
55.
go back to reference Brazier J, Ratcliffe J, Solomon JA, Tsuchia A: Measuring and Valuing Health Benefits for Economic Evaluation. 2007, New York: Oxford University Press Brazier J, Ratcliffe J, Solomon JA, Tsuchia A: Measuring and Valuing Health Benefits for Economic Evaluation. 2007, New York: Oxford University Press
56.
go back to reference Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL: Methods for the Economic Evaluation of Health Care Programmes. 2005, New York: Oxford University Press, 3 Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL: Methods for the Economic Evaluation of Health Care Programmes. 2005, New York: Oxford University Press, 3
57.
go back to reference Ramsey S, Willke R, Briggs A, Brown R, Buxton M, Chawla A, Cook J, Glick H, Liljas B, Petitti D, Reed S: Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report. Value Health. 2005, 8: 521-533. 10.1111/j.1524-4733.2005.00045.x.CrossRefPubMed Ramsey S, Willke R, Briggs A, Brown R, Buxton M, Chawla A, Cook J, Glick H, Liljas B, Petitti D, Reed S: Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report. Value Health. 2005, 8: 521-533. 10.1111/j.1524-4733.2005.00045.x.CrossRefPubMed
58.
go back to reference Tan-Torres Edejer T, Baltussen R, Adam T, Hutubessy R, Acharya A, Evans DB, Murray CJL: Making Choices in Health: WHO Guide to Cost-effectiveness Analysis. 2003, Geneva: World Health Organization Tan-Torres Edejer T, Baltussen R, Adam T, Hutubessy R, Acharya A, Evans DB, Murray CJL: Making Choices in Health: WHO Guide to Cost-effectiveness Analysis. 2003, Geneva: World Health Organization
59.
go back to reference Lodge M, Corbex M: Establishing an evidence-base for breast cancer control in developing countries. Breast (Edinburgh, Scotland). 2011, 20 (Suppl 2): S65-S69.CrossRef Lodge M, Corbex M: Establishing an evidence-base for breast cancer control in developing countries. Breast (Edinburgh, Scotland). 2011, 20 (Suppl 2): S65-S69.CrossRef
61.
go back to reference Broekx S, Hond ED, Torfs R, Remacle A, Mertens R, D'Hooghe T, Neven P, Christiaens MR, Simoens S: The costs of breast cancer prior to and following diagnosis. Eur J Health Econ. 2011, 12: 311-317. 10.1007/s10198-010-0237-3.CrossRefPubMed Broekx S, Hond ED, Torfs R, Remacle A, Mertens R, D'Hooghe T, Neven P, Christiaens MR, Simoens S: The costs of breast cancer prior to and following diagnosis. Eur J Health Econ. 2011, 12: 311-317. 10.1007/s10198-010-0237-3.CrossRefPubMed
62.
go back to reference Hanly P, Timmons A, Walsh PM, Sharp L: Breast and prostate cancer productivity costs: a comparison of the human capital approach and the friction cost approach. Value Health. 2012, 15: 429-436. 10.1016/j.jval.2011.12.012.CrossRefPubMed Hanly P, Timmons A, Walsh PM, Sharp L: Breast and prostate cancer productivity costs: a comparison of the human capital approach and the friction cost approach. Value Health. 2012, 15: 429-436. 10.1016/j.jval.2011.12.012.CrossRefPubMed
Metadata
Title
Economic analyses of breast cancer control in low- and middle-income countries: a systematic review
Authors
Sten G Zelle
Rob M Baltussen
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Systematic Reviews / Issue 1/2013
Electronic ISSN: 2046-4053
DOI
https://doi.org/10.1186/2046-4053-2-20

Other articles of this Issue 1/2013

Systematic Reviews 1/2013 Go to the issue